Brief: Lansen Pharmaceutical Sees Decrease In HY Net Profit
25/07/2019 11:26
July 25 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* EXPECTS NOTICEABLE DECREASE IN ITS NET PROFIT FOR SIX
MONTHS
* EXPECTED DECREASE DUE TO CERTAIN PROVISIONS AND WRITE-OFFS
MADE
AGAINST INVENTORY, AMONG OTHERS
Source text for Eikon: urn:newsml:reuters.com:*:nHKSbrJ4zm
Further company coverage: 0503.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year